The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prostaglandin Market Research Report 2024
Synopsis
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
The global Prostaglandin market was valued at US$ 483.4 million in 2023 and is anticipated to reach US$ 785.7 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
Europe is the largest consumption place, with a consumption market share nearly 35% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of about 27%.
CEPIA, Johnson Matthey and Pfizer are the main manufacturers of prostaglandin, they take about 65% of the whole market.
This report aims to provide a comprehensive presentation of the global market for Prostaglandin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostaglandin.
Report Scope
The Prostaglandin market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostaglandin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostaglandin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi CEPiA
Kyowa Hakko Pharma
Cayman Chemical
Yonsung Fine Chemicals
Johnson Matthey
Chirogate
Everlight Chemical
ANVI Pharma
AUSUN Pharmaceutical
Aspen Biopharma Labs
Segment by Type
Human Prostaglandin
Veterinary Prostaglandin
Segment by Application
Cardiovascular
Gynecological and Obstetrical
Ophthalmologic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prostaglandin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prostaglandin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
The global Prostaglandin market was valued at US$ 483.4 million in 2023 and is anticipated to reach US$ 785.7 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
Europe is the largest consumption place, with a consumption market share nearly 35% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of about 27%.
CEPIA, Johnson Matthey and Pfizer are the main manufacturers of prostaglandin, they take about 65% of the whole market.
This report aims to provide a comprehensive presentation of the global market for Prostaglandin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostaglandin.
Report Scope
The Prostaglandin market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostaglandin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostaglandin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi CEPiA
Kyowa Hakko Pharma
Cayman Chemical
Yonsung Fine Chemicals
Johnson Matthey
Chirogate
Everlight Chemical
ANVI Pharma
AUSUN Pharmaceutical
Aspen Biopharma Labs
Segment by Type
Human Prostaglandin
Veterinary Prostaglandin
Segment by Application
Cardiovascular
Gynecological and Obstetrical
Ophthalmologic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prostaglandin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prostaglandin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Prostaglandin Market Overview
1.1 Product Overview and Scope of Prostaglandin
1.2 Prostaglandin Segment by Type
1.2.1 Global Prostaglandin Market Value Comparison by Type (2024-2030)
1.2.2 Human Prostaglandin
1.2.3 Veterinary Prostaglandin
1.3 Prostaglandin Segment by Application
1.3.1 Global Prostaglandin Market Value by Application: (2024-2030)
1.3.2 Cardiovascular
1.3.3 Gynecological and Obstetrical
1.3.4 Ophthalmologic
1.3.5 Other
1.4 Global Prostaglandin Market Size Estimates and Forecasts
1.4.1 Global Prostaglandin Revenue 2019-2030
1.4.2 Global Prostaglandin Sales 2019-2030
1.4.3 Global Prostaglandin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Prostaglandin Market Competition by Manufacturers
2.1 Global Prostaglandin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Prostaglandin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Prostaglandin Average Price by Manufacturers (2019-2024)
2.4 Global Prostaglandin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prostaglandin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prostaglandin, Product Type & Application
2.7 Prostaglandin Market Competitive Situation and Trends
2.7.1 Prostaglandin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prostaglandin Players Market Share by Revenue
2.7.3 Global Prostaglandin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prostaglandin Retrospective Market Scenario by Region
3.1 Global Prostaglandin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Prostaglandin Global Prostaglandin Sales by Region: 2019-2030
3.2.1 Global Prostaglandin Sales by Region: 2019-2024
3.2.2 Global Prostaglandin Sales by Region: 2025-2030
3.3 Global Prostaglandin Global Prostaglandin Revenue by Region: 2019-2030
3.3.1 Global Prostaglandin Revenue by Region: 2019-2024
3.3.2 Global Prostaglandin Revenue by Region: 2025-2030
3.4 North America Prostaglandin Market Facts & Figures by Country
3.4.1 North America Prostaglandin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Prostaglandin Sales by Country (2019-2030)
3.4.3 North America Prostaglandin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prostaglandin Market Facts & Figures by Country
3.5.1 Europe Prostaglandin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Prostaglandin Sales by Country (2019-2030)
3.5.3 Europe Prostaglandin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prostaglandin Market Facts & Figures by Country
3.6.1 Asia Pacific Prostaglandin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Prostaglandin Sales by Country (2019-2030)
3.6.3 Asia Pacific Prostaglandin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Prostaglandin Market Facts & Figures by Country
3.7.1 Latin America Prostaglandin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Prostaglandin Sales by Country (2019-2030)
3.7.3 Latin America Prostaglandin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prostaglandin Market Facts & Figures by Country
3.8.1 Middle East and Africa Prostaglandin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Prostaglandin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Prostaglandin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Prostaglandin Sales by Type (2019-2030)
4.1.1 Global Prostaglandin Sales by Type (2019-2024)
4.1.2 Global Prostaglandin Sales by Type (2025-2030)
4.1.3 Global Prostaglandin Sales Market Share by Type (2019-2030)
4.2 Global Prostaglandin Revenue by Type (2019-2030)
4.2.1 Global Prostaglandin Revenue by Type (2019-2024)
4.2.2 Global Prostaglandin Revenue by Type (2025-2030)
4.2.3 Global Prostaglandin Revenue Market Share by Type (2019-2030)
4.3 Global Prostaglandin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Prostaglandin Sales by Application (2019-2030)
5.1.1 Global Prostaglandin Sales by Application (2019-2024)
5.1.2 Global Prostaglandin Sales by Application (2025-2030)
5.1.3 Global Prostaglandin Sales Market Share by Application (2019-2030)
5.2 Global Prostaglandin Revenue by Application (2019-2030)
5.2.1 Global Prostaglandin Revenue by Application (2019-2024)
5.2.2 Global Prostaglandin Revenue by Application (2025-2030)
5.2.3 Global Prostaglandin Revenue Market Share by Application (2019-2030)
5.3 Global Prostaglandin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi CEPiA
6.1.1 Sanofi CEPiA Corporation Information
6.1.2 Sanofi CEPiA Description and Business Overview
6.1.3 Sanofi CEPiA Prostaglandin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi CEPiA Prostaglandin Product Portfolio
6.1.5 Sanofi CEPiA Recent Developments/Updates
6.2 Kyowa Hakko Pharma
6.2.1 Kyowa Hakko Pharma Corporation Information
6.2.2 Kyowa Hakko Pharma Description and Business Overview
6.2.3 Kyowa Hakko Pharma Prostaglandin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Kyowa Hakko Pharma Prostaglandin Product Portfolio
6.2.5 Kyowa Hakko Pharma Recent Developments/Updates
6.3 Cayman Chemical
6.3.1 Cayman Chemical Corporation Information
6.3.2 Cayman Chemical Description and Business Overview
6.3.3 Cayman Chemical Prostaglandin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cayman Chemical Prostaglandin Product Portfolio
6.3.5 Cayman Chemical Recent Developments/Updates
6.4 Yonsung Fine Chemicals
6.4.1 Yonsung Fine Chemicals Corporation Information
6.4.2 Yonsung Fine Chemicals Description and Business Overview
6.4.3 Yonsung Fine Chemicals Prostaglandin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Yonsung Fine Chemicals Prostaglandin Product Portfolio
6.4.5 Yonsung Fine Chemicals Recent Developments/Updates
6.5 Johnson Matthey
6.5.1 Johnson Matthey Corporation Information
6.5.2 Johnson Matthey Description and Business Overview
6.5.3 Johnson Matthey Prostaglandin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson Matthey Prostaglandin Product Portfolio
6.5.5 Johnson Matthey Recent Developments/Updates
6.6 Chirogate
6.6.1 Chirogate Corporation Information
6.6.2 Chirogate Description and Business Overview
6.6.3 Chirogate Prostaglandin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Chirogate Prostaglandin Product Portfolio
6.6.5 Chirogate Recent Developments/Updates
6.7 Everlight Chemical
6.6.1 Everlight Chemical Corporation Information
6.6.2 Everlight Chemical Description and Business Overview
6.6.3 Everlight Chemical Prostaglandin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Everlight Chemical Prostaglandin Product Portfolio
6.7.5 Everlight Chemical Recent Developments/Updates
6.8 ANVI Pharma
6.8.1 ANVI Pharma Corporation Information
6.8.2 ANVI Pharma Description and Business Overview
6.8.3 ANVI Pharma Prostaglandin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 ANVI Pharma Prostaglandin Product Portfolio
6.8.5 ANVI Pharma Recent Developments/Updates
6.9 AUSUN Pharmaceutical
6.9.1 AUSUN Pharmaceutical Corporation Information
6.9.2 AUSUN Pharmaceutical Description and Business Overview
6.9.3 AUSUN Pharmaceutical Prostaglandin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AUSUN Pharmaceutical Prostaglandin Product Portfolio
6.9.5 AUSUN Pharmaceutical Recent Developments/Updates
6.10 Aspen Biopharma Labs
6.10.1 Aspen Biopharma Labs Corporation Information
6.10.2 Aspen Biopharma Labs Description and Business Overview
6.10.3 Aspen Biopharma Labs Prostaglandin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Aspen Biopharma Labs Prostaglandin Product Portfolio
6.10.5 Aspen Biopharma Labs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prostaglandin Industry Chain Analysis
7.2 Prostaglandin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prostaglandin Production Mode & Process
7.4 Prostaglandin Sales and Marketing
7.4.1 Prostaglandin Sales Channels
7.4.2 Prostaglandin Distributors
7.5 Prostaglandin Customers
8 Prostaglandin Market Dynamics
8.1 Prostaglandin Industry Trends
8.2 Prostaglandin Market Drivers
8.3 Prostaglandin Market Challenges
8.4 Prostaglandin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
